PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1887115
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1887115
The global medical nutrition market continues to expand steadily as chronic diseases rise, awareness of clinical nutrition grows, and healthcare systems worldwide increasingly recognize the importance of nutrition therapy in both acute and long-term care. According to the report, the market size reached USD 51.26 billion in 2024, driven by an aging global population and increasing demand for medical nutrition therapy (MNT). The market is projected to grow further to USD 52.94 billion in 2025 and eventually reach USD 85.05 billion by 2032, reflecting a 7.0% CAGR during the forecast period. North America dominated the global market in 2024, accounting for 34.96% of total revenue due to its strong healthcare infrastructure, high prevalence of chronic diseases, and growing partnerships to advance clinical nutrition solutions.
Key Market Insights
Medical Nutrition Therapy (MNT) involves tailored nutrition interventions used to manage conditions such as diabetes, gastrointestinal disorders, cardiovascular diseases, chronic respiratory illness, and kidney disease. This treatment utilizes nutrition education and behavioral counseling delivered by clinical dietitians as part of multidisciplinary medical care. In recent years, demand has surged due to growing global awareness about the importance of nutrition in preventing and managing chronic conditions.
The market is semi-consolidated with major players such as Abbott, Nestle, Nutricia (Danone), B. Braun SE, Fresenius Kabi AG, and Reckitt Benckiser Group PLC. These companies continue to expand portfolios and secure regulatory approvals to introduce disease-specific and patient-focused nutritional products. For example, in April 2023, Nutricia launched a memory supplement in the U.S. to support synapse strengthening.
Market Dynamics
Drivers: Rising Burden of Chronic Diseases
The increasing prevalence of chronic illnesses significantly boosts market demand. Conditions such as cancer, Parkinson's disease, and neurological disorders often impair normal nutrient intake. According to the American Parkinson Disease Association, 1.3 million people in North America will be living with Parkinson's disease by 2030. Similarly, aging populations contribute heavily to chronic conditions requiring clinical nutrition. In the U.S., 17.3% of the population was aged 65+ in 2022, a number projected to reach 22.0% by 2040.
Growing awareness of home-based medical nutrition also fuels demand, as elderly patients increasingly prefer clinical nutrition services at home for convenience, improved mobility, and enhanced quality of life.
Restraints: Limited Reimbursement Policies
Coverage for medical foods and nutrition therapies varies widely across regions. While countries in Europe such as France, Germany, Spain, and the Netherlands offer substantial reimbursement, the U.S. provides limited coverage outside hospital settings. This restricts access for lower-income patients. Additionally, lack of financial incentives for research in clinical nutrition technologies can deter innovation.
Opportunities: AI-Powered Personalized Nutrition
Rising demand for disease-specific and personalized nutrition products creates significant opportunities for manufacturers. Companies such as Abbott are increasing R&D investments-USD 2,741.0 million in 2023-into AI-enhanced nutrition solutions for gastrointestinal disorders, immune health, and metabolic conditions. Advances in AI are enabling accurate nutrition delivery and real-time monitoring for critically ill patients.
Market Trends
A major trend in the market is the shift toward disease-specific formulations, such as those for oncology, renal disorders, and metabolic diseases. Companies are launching specialized formulas to improve treatment outcomes. For instance, Abbott introduced its Similac PM 60/40 metabolic formula to support infants with specific renal conditions.
Personalized nutrition is also gaining traction, particularly in Japan, where 53% of consumers express interest in tailored nutritional solutions. Additionally, global focus on preventive healthcare is rising, positioning clinical nutrition as an essential tool for disease prevention.
North America
North America led the global market with a value of USD 17.92 billion in 2024, supported by strong R&D, product launches, and collaborations. Companies frequently introduce new solutions at major U.S. medical conferences. Baxter's ExactaMix Pro launch in 2022 is an example of growing innovation in the region.
Europe
Europe held the second-largest share in 2024, driven by favorable reimbursement policies and strong research collaborations like the Fresenius Kabi-ESICM partnership supporting clinical nutrition education and critical care nutrition.
Asia Pacific
Asia Pacific is expected to grow moderately from 2025 to 2032, fueled by an expanding elderly population and rising awareness of disease-specific nutrition. Economic development and increased healthcare spending are supporting market expansion in China, India, and Japan.
Latin America and Middle East & Africa
These regions are witnessing steady growth due to improving healthcare access, rising chronic diseases, and increased awareness of nutrition therapy.
Conclusion
Driven by rising chronic diseases, aging populations, and increased focus on personalized care, the medical nutrition market will grow from USD 51.26 billion in 2024 to USD 85.05 billion by 2032. Continued innovation, AI-integrated nutrition solutions, and strategic collaborations will shape the future of clinical nutrition worldwide.
Growth rate CAGR of 7.0% from 2025-2032
Segmentation
By Type
By Age Group
By Route of Administration
By Form
By Therapeutic Area
By End-user
By Region